In Re Lorazepam & Clorazepate Antitrust Litigation
631 F.3d 537
| D.C. Cir. | 2011Background
- Four health insurers sue Mylan and chemical suppliers under state antitrust laws for exclusive licensing effects on self-funded customers who bear the insurance costs.
- Self-funded customers are entities that pay benefits directly; plaintiffs sue on their behalf as third-party administrators and as real parties in interest for damages.
- Self-funded customers are the real and substantial parties with rights to sue; plaintiffs cannot merely act as agents and must count those customers for diversity purposes.
- District court allowed claims to proceed under Rule 17(a)(1) and then attempted a voluntary ratification process by having self-funded customers opt in.
- Defendants later argued lack of complete diversity because at least one nondiverse self-funded customer (e.g., 3M) existed, potentially destroying jurisdiction.
- The court remanded to permit Rule 21 dismissal of nondiverse parties to restore complete diversity, with possible partial retrial on damages; merits remain undecided.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether self-funded customers count for diversity purposes | Self-funded customers are real parties in interest and must be counted | These customers are not formal parties in the action | Yes, self-funded customers must be counted; their presence can destroy complete diversity |
| Whether complete diversity exists given a nondiverse self-funded party | Diversity remains under Rule 1367 | Nondiverse party destroys jurisdiction under Strawbridge | Nondiverse party destroys diversity; remand for Rule 21 proceedings to drop them |
| Whether supplemental jurisdiction can salvage the action despite lack of complete diversity | Allapattah supports supplemental jurisdiction over related claims | Allapattah does not override Strawbridge; diversity contamination remains | Supplemental jurisdiction cannot cure lack of complete diversity; case remanded for Rule 21 analysis |
| Timing of jurisdiction with respect to when self-funded customers become parties | Jurisdiction attaches when suit commenced | Jurisdiction depends on later developments | Jurisdiction under Mollan depends on status at filing; self-funded status established with suit commencement |
| Appropriate remedy given lack of jurisdiction | Proceed with remaining claims after ratifying/dropping parties | May require dismissal of nondiverse parties | Remand to district court to determine which self-funded customers may be dropped to restore complete diversity |
Key Cases Cited
- Capron v. Van Noorden, 6 U.S. (2 Cranch) 126 (1804) (jurisdiction cannot be conferred by consent; jurisdiction defects may be raised on appeal)
- Strawbridge v. Curtiss, 7 U.S. (3 Cranch) 267 (1806) (complete diversity required among all plaintiffs and defendants)
- Mollan v. Torrance, 22 U.S. (9 Wheat.) 537 (1824) (jurisdiction depends on state of things at time of action brought)
- Exxon Mobil Corp. v. Allapattah Servs., 545 U.S. 546 (2005) (§1367 may permit hearing related claims but not overcome lack of complete diversity)
- Associated Ins. Mgmt. Corp. v. Ark. Gen. Agency, 149 F.3d 794 (8th Cir. 1998) (treats self-funded customers as real parties for diversity considerations)
